Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter in China

NCT02027012 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT02027012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02027012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter in China
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2014
Completion date
September 30, 2015
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medication-resistant hypertension